Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age

NCT00113880 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00113880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00113880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age
Lead sponsor
MedImmune LLC
Phase
Observational
Overall status
Completed
Start date
October 31, 2003
Completion date
June 30, 2010
Enrollment
63,061 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

healthy